|
|||||
|
|
Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence |
|
| Authors: | Martínez-Salamanca Juan I Carballido Joaquin Eardley Ian Giuliano Francois Gratzke Christian Rosen Raymond Salonia Andrea Stief Christian |
| Affiliation: | a Department of Urology, Hospital Universitario Puerta de Hierro-Majadahonda, Universidad Autónoma de Madrid, Madrid, Spain b Department of Urology, St. James University Hospital, Leeds, UK c AP-HP, Neuro-Uro-Andrology, Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, Garches, EA 4501 Versailles Saint Quentin en Yvelines University, France d Department of Urology, Ludwig-Maximilians-University Munich, Campus Grosshadern, Munich, Germany e New England Research Institutes, Watertown, MA, USA f Department of Urology, University Vita-Salute San Raffaele, Milan, Italy |
| Abstract: | |
| Keywords: | Lower urinary tract symptoms Benign prostatic hyperplasia Bladder neck PDE receptors Phosphodiesterase inhibitors Cavernous tissue Erectile dysfunction Sildenafil Vardenafil Tadalafil Udenafil Alfuzosin Tamsulosin UK-369003 |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |